Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H23NO2.C6H8O7 |
| Molecular Weight | 453.4828 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCOC(=O)C1(CCCN(C)CC1)C2=CC=CC=C2
InChI
InChIKey=KCVHFFSPDODYOG-UHFFFAOYSA-N
InChI=1S/C16H23NO2.C6H8O7/c1-3-19-15(18)16(14-8-5-4-6-9-14)10-7-12-17(2)13-11-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-6,8-9H,3,7,10-13H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
| Molecular Formula | C6H8O7 |
| Molecular Weight | 192.1235 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H23NO2 |
| Molecular Weight | 261.3593 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Ethoheptazine is an analgesic, which belongs to the proheptazine group. It was used either alone (Zactane trade name) or in combination with meprobamate and aspirin (Equagesic) for the pain relief in patients with headache or musculoskeletal disorders. Currently all mediactions containing ethoheptazine are withdrawn from the market. The exact target of ethoheptazine is unknow, but it is believed that it may have modulatory effect on opioid receptors.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095181 Sources: https://www.google.co.jp/patents/WO2006138186A1 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | EQUAGESIC Approved UseEquagesic is possibly effective in the treatment of pain accompained by tension and anxiety in patients with musculoskeletal disease or tension headache. |
|||
| Primary | EQUAGESIC Approved UseEquagesic is possibly effective in the treatment of pain accompained by tension and anxiety in patients with musculoskeletal disease or tension headache. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobamate: a comparative study in acute low back pain. | 1987-02 |
|
| Fixed drug eruption masquerading as herpes simplex labialis. | 1984-09-29 |
|
| Determination of ethoheptazine in human post mortem material. | 1983-10-14 |
|
| Effects of propoxyphene, ethoheptazine, and azabicyclane on schedule-controlled responding: attenuation by pentobarbital but not naloxone. | 1979 |
|
| Treatment of musculoskeletal pain and associated anxiety with an ethoheptazine-aspirin-meprobamate combination (equagesic): a controlled study. | 1974-09 |
|
| Clinical comparison of ethoheptazine and aspirin with other analgesic combinations. | 1961-03 |
|
| Methods in evaluating ethoheptazine and ethoheptazine combined with aspirin. | 1958-04-12 |
|
| Analgesic effectiveness of orally administered ethoheptazine in man. | 1957-10 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:05 GMT 2025
by
admin
on
Mon Mar 31 17:35:05 GMT 2025
|
| Record UNII |
LXK8EE245D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DBSALT001084
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
m1138
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | Merck Index | ||
|
6700-56-7
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
100000087280
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
C76841
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
235416
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | RxNorm | ||
|
229-743-0
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
SUB02001MIG
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
CHEMBL170797
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
23165
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
LXK8EE245D
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY | |||
|
2085-42-9
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID80943103
Created by
admin on Mon Mar 31 17:35:05 GMT 2025 , Edited by admin on Mon Mar 31 17:35:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |